We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Wyeth Pharmaceuticals has received a warning letter from the FDA identifying current good manufacturing practice (cGMP) violations ranging from impurities in drugs to improper cleaning of packing machines at its Guayama, Puerto Rico, facility.